Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5537)
All Articles published online
|
Publishing Process of This Article
|
Jan 15, 2022 (publication date) through May 23, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Uemura N, Hayashi H, Baba H. Statin as a therapeutic agent in gastroenterological cancer. World J Gastrointest Oncol 2022; 14(1): 110-123 [PMID: 35116106 DOI: 10.4251/wjgo.v14.i1.110] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v14/i1/110.htm |
| Number | Citing Articles |
| 1 |
Elena Crecca, Gianfranco Di Giuseppe, Claudia Camplone, Virginia Vigiano Benedetti, Ombretta Melaiu, Teresa Mezza, Chiara Cencioni, Francesco Spallotta. The multifaceted role of agents counteracting metabolic syndrome: A new hope for gastrointestinal cancer therapy. Pharmacology & Therapeutics 2025; 270: 108847 doi: 10.1016/j.pharmthera.2025.108847
|
| 2 |
Gamaleldin I. Harisa, Ahmed H. Bakheit, Samiyah Alshehri, Sabry M. Attia, Mohamed S. M. Attia. Chitosan-enclosed SLN improved SV-induced hepatocellular cell carcinoma death by modulation of IQGAP gene expression, JNK, and HDAC activities. Molecular Biology Reports 2024; 51(1) doi: 10.1007/s11033-024-09757-2
|
| 3 |
Elham Norouz Dolatabadi, Vahid Asghariazar, Maryam Darvish, Kazem Nejati-Koshki. Simvastatin-loaded PCL/PEG nanofibrous scaffold: A prospective approach for suppression 5-fluorouracil resistance in MKN-45 gastric cancer cells. Journal of Drug Delivery Science and Technology 2023; 80: 104104 doi: 10.1016/j.jddst.2022.104104
|
| 4 |
Abdelrahman Y. Sherif, Gamaleldin I. Harisa, Ahmad A. Shahba, Fahd A. Nasr, Ehab I. Taha, Ali S. Alqahtani. Assembly of nanostructured lipid carriers loaded gefitinib and simvastatin as hybrid therapy for metastatic breast cancer: Codelivery and repurposing approach. Drug Development Research 2023; 84(7): 1453 doi: 10.1002/ddr.22097
|
| 5 |
RIYAD F. ALZHRANI, ABDULRAHMAN A. ALLUHAIDAN, SULTAN M. ALAMRI, GAMALELDIN I. HARISA, AHMED H. BAKHEIT, HANADI H. ASIRI, SABRY M. ATTIA. Chitosan capped-NLCs enhanced codelivery of gefitinib and simvastatin into MDR HCC: impact of compositions on cell death, JNK3, and Telomerase. Oncology Research 2025; 33(2): 477 doi: 10.32604/or.2024.053337
|
| 6 |
Yinsong Xu, Yuanzhi Li. Association between lipid-lowering drugs and allergic diseases: A Mendelian randomization study. World Allergy Organization Journal 2024; 17(4): 100899 doi: 10.1016/j.waojou.2024.100899
|
| 7 |
Armin Khaghani, Karamali Kasiri, Saeid Heidari-Soureshjani, Catherine M.T. Sherwin, Hossein Mardani-Nafchi. A Systematic Review and Meta-analysis of the Relationship between Statin Intake
and Esophageal Cancer. Anti-Cancer Agents in Medicinal Chemistry 2024; 24(14): 1029 doi: 10.2174/0118715206292712240522043350
|